Court Issues Claim Construction Order in Illumina's Suit Against Complete Genomics | GenomeWeb

This story was originally published Feb. 16.

Illumina said last week that the US District Court for the Northern District of California has issued a claim construction order in litigation brought by Illumina against Complete Genomics.

A claim construction order is a legal procedure in which a judge sets the definition of terms that comprise the patent claims.

According to Illumina, the order adopts constructions that are "favorable" for the "key terms of the dispute."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.